Avantor (AVTR) is a public company. Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.

Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.

Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.

More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively.

Visit our website to learn more about Avantor. Founded in 1904. It has 12,812 employees.

Transcript

Operator

Good morning. My name is Krista, and I'll be your conference operator today. At this time, I would like to welcome everyone to Avantor's Second Quarter 2026 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question at that time, simply press star then the number one on your telephone keypad. If you'd like to withdraw your question, again, press star one. Thank you. I will now like to turn the conference over to Chris Fidyk, Vice President of Investor Relations. Chris, you may begin.

Chris Fidyk — VP of Investor Relations

Thank you, operator. Good morning, everyone, and thank you for joining us. Our speakers today are Emmanuel Ligner, President and Chief Executive Officer, and Steven Eck, Senior Vice President, Interim Chief Financial Officer, and Chief Accounting Officer. The press release and our presentation accompanying this call are available on our investor relations website at ir.avantorsciences.com. Following our prepared remarks, we'll open the call for questions. A replay of the call will be made available on our website later today. During this call, we will make forward-looking statements within the meaning of the U.S. Federal securities laws, including statements regarding